INTRODUCTION

The relationship between serum uric acid levels and a variety of cardiovascular conditions have been reported since the early 1960s [1]. Metabolic syndrome is defined by a clustering of risk factors for cardiovascular disease [2,3]. An increasing prevalence of metabolic syndrome has been reported in Korea [4,5]. The higher serum uric acid level of hyperuricemia has been associated with metabolic syndrome in studies of health screenees [3,6-9] and in nationwide surveys [10,11]. However, the direct association between uric acid levels and metabolic syndrome remains controversial, and most clinical guidelines do not recommend treating asymptomatic hyperuricemia [12]. Moreover, serum uric acid levels within a normal to high range have not been fully evaluated in association with metabolic syndrome. Therefore, we evaluated the association of serum uric acid levels with metabolic syndrome in a rural population in Korea.

METHODS

I. Participants

This study is a cross-sectional analysis of baseline data of a community-based prospective cohort, which started in 2006 on Kanghwa Island, South Korea. This analysis enrolled participants who attended a health examination in 2008 or 2009 because serum uric acid testing has been available since 2008. Among the initial total of 2396 participants, we excluded 8 participants because their uric acid levels were not measured. An additional 8 participants were excluded for the following reasons: absence of systolic blood pressure (SBP) or <60 mmHg, absence of diastolic blood pressure (DBP) or <40 mmHg, absence of pulse rates or >700 beats/min or <30 beats/min, and triglycerides >1500 mg/dL. A final total of 2380 participants (male 889, female 1491) were enrolled in this study. All participants signed written informed consent forms, and the Institutional Review Board approved the study protocol.

II. Definition of Metabolic Syndrome

Metabolic syndrome was determined according to the criteria of the National Cholesterol Education Program Adult Treatment Panel III, except for waist circumference, where the Asian cutoffs were used. Thus, metabolic syndrome was defined as the presence of three or more of the following five criteria: 1) waist circumference ≥ 90 cm in males and ≥80 cm in females, 2) triglycerides ≥150 mg/dL or under treatment for elevated triglycerides, 3) high-density lipoprotein (HDL)-cholesterol < 40 mg/dL in males and < 50 mg/dL in females or under treatment for reduced HDL, 4) SBP ≥130 mmHg or DBP ≥85 mmHg or under treatment for hypertension, and 5) fasting glucose ≥100 mg/dL or under treatment for elevated glucose [13].

III. Measuring Study Variables

Detailed methods for the measurements used in the Korean Genome and Epidemiology Study: Kanghwa study were previously reported elsewhere [14-16]. Trained personnel measured the anthropometric variables according to the written protocol. Waist circumference was measured on a horizontal plane midway between the inferior margin of the ribs and the superior border of the iliac crest using a tape measure (SECA-200; SECA, Hamburg, Germany). Resting blood pressure was measured twice with at least 5 minute intervals using an automatic sphygmomanometer (Dinamap 1846 SX/P; GE Healthcare, Waukesha, WI, USA). If the difference between the first and second measurement was more than 10 mmHg, then repeated measurements were performed. The average of the last two measurements was used for the analysis. Blood samples were collected from the antecubital vein after at least an 8 hour fast. Enzymatic methods were applied to measure fasting plasma glucose, serum uric acid, triglycerides, total cholesterol, and HDL cholesterol (ADVIA 1650; Siemens Healthcare Diagnostics Inc., Deerfield, IL, USA). Serum uric acid levels were divided into separate quartiles for males and females. Sex-specific serum uric acid quartiles were used as follows: <4.8, 4.8-<5.6, 5.6-<6.5, ≥6.5 mg/dL in males; and <3.8, 3.8-<4.3, 4.3-<5.1, ≥5.1 mg/dL in females.

IV. Statistical Analysis

Prior to performing statistical analysis, the levels of triglycerides, fasting glucose, and C-reactive protein were log-transformed because of the skewed distribution. The differences between the investigated variables' means according to sex-specific serum uric acid quartiles were tested using the chi-squared test and analysis of variance. The relationships between serum uric acid levels and other variables were assessed using the Pearson's correlation coefficients. The trend test was performed to determine the trends with the number of metabolic abnormalities and prevalence of metabolic syndrome according to the serum uric acid quartile. The association between the sex-specific serum uric acid quartile and metabolic syndrome were tested using multivariate logistic regression analysis. We calculated the unadjusted and adjusted odds ratios (ORs) using the lowest quartile as the reference. In the adjusted model, we controlled age, smoking status (current smoker vs. others), alcohol intake (current drinker vs. others), body mass index (BMI), total cholesterol, HbA1c, albumin, blood urea nitrogen (BUN), γ-glutamyltransferase, and log C-reactive protein. Controlled variables were selected based on the following criteria. Age, smoking status, alcohol intake, and BMI were first selected after the literature had been reviewed, whereas sex was stratified. The variables that did not exceed 0.3 of the correlation p-value were then contained, after which the stepwise method was used. BUN was then additionally adjusted as a marker of kidney function. All statistical analyses were performed using SAS version 9.2.0 (SAS Inc., Cary, NC, USA). We used a two-tailed test, and a value of p<0.05 was considered to be statistically significant.

RESULTS

The characteristics of the study participants are summarized in Table 1 according to the sex-specific quartile of the serum uric acid levels. The age distribution was different for males and females. The higher quartiles of serum uric acid levels tended to be associated with younger ages in males, but older ages in females.

I. Relationship Between Serum Uric Acid Level and Investigated Variables

Serum uric acid levels had positive correlations with waist circumference, BMI, SBP, total protein, albumin, aspartate aminotransferase, alanine aminotransferase, γ-glutamyltransferase, BUN, creatinine, log triglycerides, fasting insulin, and log C-reactive protein and an inverse correlation with HDL-cholesterol level in both sexes (Table 2). Age was negatively correlated with serum uric acid in males, but positively correlated in females. The pulse rate was positively correlated with serum uric acid in males (coefficient 0.087, p-value 0.010). However, total cholesterol, fasting glucose, and HbA1c were positively correlated with serum uric acid in females.

II. Association Between Serum Uric Acid Quartiles and Metabolic Syndrome

The number of metabolic abnormalities according to the serum uric acid quartile is shown in Figure 1. The number of metabolic syndrome components increased gradually with increasing serum uric acid quartile before (p for trend <0.001 in both sexes) and after adjustment (p for trend <0.001 in both sexes). The prevalence of metabolic syndrome also increased gradually with an increasing serum uric acid quartile before (p for trend <0.001 in both sexes) and after adjustment (p for trend <0.001 in both sexes) in Figure 2.

The highest quartile had a higher OR for metabolic syndrome than the lowest quartile after adjusting for age, smoking, alcohol intake, BMI, total cholesterol, HbA1c, albumin, BUN, γ-glutamyltransferase, and log C-reactive protein in both sexes (Table 3). Presence of metabolic syndrome significantly increased in the second, third, and fourth quartiles of serum uric acid levels in males, but at the third and fourth quartiles of serum uric acid levels in females.

DISCUSSION

We evaluated the associations of serum uric acid levels with metabolic syndrome in a rural population in Korea. We found that higher serum uric acid levels, even within the normal ranges, were associated with an increased prevalence of metabolic syndrome in both sexes even after adjusting for confounding factors.

Uric acid is the final product of purine metabolism and is excreted via the urine in higher primates [17,18]. Particularly in humans, over half of the antioxidant capacity of blood plasma comes from uric acid [18]. Reports have shown that serum uric acid levels have been increasing since 1960s in the US population, and this is possibly associated with the cardiovascular disease epidemic that has occurred over the last 100 years [19]. There is increasing evidence that uric acid plays a role in the development of metabolic syndrome. Animal studies have shown that decreasing uric acid levels may prevent or reverse the course of metabolic syndrome. One of the possible biological mechanisms is related to insulin-stimulated endothelial nitric oxide synthesis. Insulin-stimulated endothelial nitric oxide synthase (eNOS) regulates blood flow, influencing glucose uptake in skeletal muscle [1]. Animal studies have also shown that hyperuricemia caused by eNOS, and impaired eNOS, are associated with metabolic syndrome [1,20,21]. Another study showed that treatment for hyperuricemia patients improved endothelial dysfunction [1,22]. Therefore, we suggest that hyperuricemia could induce endothelial cell dysfunction and contribute to the development of metabolic syndrome. Another possible mechanism is related to inflammation and oxidative stress. Uric acid in adipocytes of obese mice induced inflammatory oxidative changes: hence the resulting development of metabolic syndrome [23-25].

Our findings are, in general, consistent with previous reports [3,6-11], but can be distinguished from them. First, our study population consisted of community-dwellers rather than institutionalized patients or health screenees, thereby potentially reducing selection bias.

Second, our study showed that higher serum uric acid levels, even within the normal ranges, were associated with metabolic syndrome. Serum uric acid levels ranged from 0.6 to 10.8 mg/dL in our participants. Most previous studies have investigated the association between frank hyperuricemia (defined as more than 6 mg/dL in females and more than 7 mg/dL in males) [1,9,10,26-28] with metabolic syndrome. Third, we investigated the association between serum uric acid level and metabolic syndrome in males and females separately, and the strength of association differed between sexes (Table 3). Fasting glucose and HbA1c were positively correlated with serum uric acid only in females, but not in males (Table 2). We cannot clearly explain these differences by sex; however, one of the possible explanations for the differences might be a nonlinear relationship between uric acid level and glucose metabolism. Serum uric acid levels have different distributions in males and females. The range of the second quartile in males (4.8-<5.6 mg/dL) is similar to that of the third quartile in females (4.3-<5.1 mg/dL). Moreover, there might be different distributions of serum uric acid levels for men and women with diabetes, prediabetes, and using anti-diabetic medication. If serum uric acid levels have non-linear relationships with diabetes or metabolic syndrome, then the direction and strength of association could be different for males and females. A previous study reported an inverse U-shaped association between fasting glucose and uric acid levels; fasting glucose levels lower than 8.0 mmol/L were positively associated with uric acid, but glucose levels higher than 8.0 mmol/L were inversely associated [29].

Because this study is limited due to its cross-sectional nature, we could not assess temporal relationships. It is also possible that residual or unmeasured confounding variables may exist. Some information was unavailable from the data used in this study, such as history of gout or kidney diseases, which might have influenced the serum uric acid levels. Therefore, we adjusted for BUN as an alternative marker of kidney function. However, further prospective investigations are required to fully understand the causal relationship between serum uric acid levels and the development of metabolic syndrome.

Our results suggest that individuals with high normal uric acid levels or asymptomatic hyperuricemia are at risk of metabolic syndrome. Intensive lifestyle modifications may be required for such individuals. Currently, most health screening examinations include a serum uric acid test, but physicians do not pay attention to uric acid levels unless the screenees have symptoms of gout. Physicians should explain the risks of metabolic syndrome or cardiovascular disease to individuals with high uric acid levels and recommend lifestyle modifications or consider preventive medical intervention.

In conclusion, higher serum uric acid levels are positively associated with the presence of metabolic syndrome in Korean males and females.

ACKNOWLEDGEMENTS

Notes

The authors have no conflicts of interest with the material presented in this paper.

This article is available at http://jpmph.org/.

REFERENCES

• 1. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008;359(17):1811-1821. 18946066ArticlePubMedPMC
• 2. Kim HC, Kang DR, Choi KS, Nam CM, Thomas GN, Suh I. Spousal concordance of metabolic syndrome in 3141 Korean couples: a nationwide survey. Ann Epidemiol 2006;16(4):292-298. 16230025ArticlePubMed
• 3. Oh HJ, Moon SH, Lee JW, Hyun HY, Lee DC, Lee HR. Relationship between serum uric acid and metabolic syndrome. J Korean Acad Fam Med 2006;27(9):699-705. (Korean)
• 4. Lim S, Park KS, Lee HK, Cho SI. Korean National Health and Nutrition Examination Surveys. Changes in the characteristics of metabolic syndrome in Korea over the period 1998-2001 as determined by Korean National Health and Nutrition Examination Surveys. Diabetes Care 2005;28(7):1810-1812. 15983345ArticlePubMed
• 5. Lim S, Shin H, Song JH, Kwak SH, Kang SM, Won Yoon J, et al. Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007. Diabetes Care 2011;34(6):1323-1328. 21505206ArticlePubMedPMC
• 6. Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol 2005;25(5):1038-1044. 15746438ArticlePubMed
• 7. Lim JH, Kim YK, Kim YS, Na SH, Rhee MY, Lee MM. Relationship between serum uric acid levels, metabolic syndrome, and arterial stiffness in Korean. Korean Circ J 2010;40(7):314-320. 20664739ArticlePubMedPMC
• 8. Lin SD, Tsai DH, Hsu SR. Association between serum uric acid level and components of the metabolic syndrome. J Chin Med Assoc 2006;69(11):512-516. 17116612ArticlePubMed
• 9. Kim SK, Park HA, Nam OY, Beck SH, Whang DH, Hwang UK, et al. Risk of the metabolic syndrome according to the level of the uric acid. J Korean Acad Fam Med 2007;28(6):428-435. (Korean)
• 10. Choi HK, Ford ES. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 2007;120(5):442-447. 17466656ArticlePubMed
• 11. Onat A, Uyarel H, Hergenc G, Karabulut A, Albayrak S, Sari I, et al. Serum uric acid is a determinant of metabolic syndrome in a population-based study. Am J Hypertens 2006;19(10):1055-1062. 17027827ArticlePubMed
• 12. Longo DL, Kasper DL, Braunwald E, Fauci AS, Harrison TR, Hauser SL, et al. Harrison's principles of internal medicine. 2008. 17th ed. New York: McGraw-Hill Medical; p. 2447
• 13. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112(17):2735-2752. 16157765ArticlePubMed
• 14. Lee JY, Ahn SV, Choi DP, Suh M, Kim HC, Kim YS, et al. Association between hypertension and pulmonary function in rural adults in Korea. J Prev Med Public Health 2009;42(1):21-28. (Korean). 19229121ArticlePubMedPDF
• 15. Oh SM, Kim HC, Ahn SV, Chi HJ, Suh I. Association between meat consumption and carotid intima-media thickness in Korean adults with metabolic syndrome. J Prev Med Public Health 2010;43(6):486-495. 21139409ArticlePubMedPDF
• 16. Suh M, Lee JY, Ahn SV, Kim HC, Suh I. C-reactive protein and carotid intima-media thickness in a population of middle-aged Koreans. J Prev Med Public Health 2009;42(1):29-34. (Korean). 19229122ArticlePubMedPDF
• 17. Kang DH. Potential role of uric Acid as a risk factor for cardiovascular disease. Korean J Intern Med 2010;25(1):18-20. 20195398ArticlePubMedPMC
• 18. Uric acid. Wikipedia. cited 2011 Mar 4. Available from: http://en.wikipedia.org/wiki/Uric_acidArticle
• 19. Glynn RJ, Campion EW, Silbert JE. Trends in serum uric acid levels 1961-1980. Arthritis Rheum 1983;26(1):87-93. 6824508ArticlePubMed
• 20. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005;67(5):1739-1742. 15840020ArticlePubMed
• 21. Cook S, Hugli O, Egli M, Vollenweider P, Burcelin R, Nicod P, et al. Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice. Swiss Med Wkly 2003;133(25-26):360-363. 12947532ArticlePubMed
• 22. Mercuro G, Vitale C, Cerquetani E, Zoncu S, Deidda M, Fini M, et al. Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol 2004;94(7):932-935. 15464681ArticlePubMed
• 23. Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 2007;293(2):C584-C596. 17428837ArticlePubMed
• 24. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114(12):1752-1761. 15599400ArticlePubMedPMC
• 25. Cheung KJ, Tzameli I, Pissios P, Rovira I, Gavrilova O, Ohtsubo T, et al. Xanthine oxidoreductase is a regulator of adipogenesis and PPARgamma activity. Cell Metab 2007;5(2):115-128. 17276354ArticlePubMed
• 26. Feig DI, Johnson RJ. Hyperuricemia in childhood primary hypertension. Hypertension 2003;42(3):247-252. 12900431ArticlePubMedPMC
• 27. Niskanen LK, Laaksonen DE, Nyyssonen K, Alfthan G, Lakka HM, Lakka TA, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004;164(14):1546-1551. 15277287ArticlePubMed
• 28. Nakagawa T, Tuttle KR, Short RA, Johnson RJ. Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract Nephrol 2005;1(2):80-86. 16932373ArticlePubMed
• 29. Cook DG, Shaper AG, Thelle DS, Whitehead TP. Serum uric acid, serum glucose and diabetes: relationships in a population study. Postgrad Med J 1986;62(733):1001-1006. 3628142ArticlePubMedPMC

Figure 1

The number of metabolic abnormalities according to the serum uric acid quartile.

¹Adjusted for age, smoking, alcohol intake, body mass index, total cholesterol, HbA1c, albumin, blood urea nitrogen, γ-glutamyltransferase, and log CRP.

²Number of following metabolic abnormalities: 1) waist circumstance ≥90 cm in male and ≥80 cm in female, 2) triglycerides ≥150 mg/dL or under treatment for elevated triglycerides, 3) high-density lipoprotein (HDL)-cholesterol <40 mg/dL in male and <50 mg/dL in female or under treatment for reduced HDL, 4) SBP ≥130 mmHg or DBP ≥85 mmHg or under treatment for hypertension, 5) fasting glucose ≥100 mg/dL or under.

Figure 2

Prevalence of metabolic syndrome according to the serum uric acid quartile

¹Adjusted for age, smoking, alcohol intake, body mass index, total cholesterol, HbA1c, albumin, blood urea nitrogen, γ-glutamyltransferase, and log CRP.

Table 1.

Characteristics of the participants according to serum uric acid level

Variables	Serum uric acid quartile (mg/dL)				p - value
	< 4.8 (n = 197)	4.8 - < 5.6 (n = 225)	5.6 - < 6.5 (n = 230)	≥ 6.5 (n = 237)
Male (n=889)
Age (y)	61.1±7.9	59.3±8.3	58.8±7.5	58.4 ±8.5	0.003
Body mass index (kg/m2)	23.8±3.0	24.0±2.7	24.7±2.7	25.3±2.9	<0.001
Waist circumference (cm)	85.6±7.8	86.2±7.4	87.5±6.8	89.1±7.2	<0.001
SBP (mmHg)	120.7±16.6	122.6±15.3	121.3±16.1	123.3±17.0	0.32
DBP (mmHg)	75.1±9.3	77.0±9.4	77.8±9.7	78.6±9.1	0.001
Total protein (g/dL)	7.4±0.4	7.4±0.4	7.5±0.4	7.6±0.4	<0.001
Albumin (g/dL)	4.4±0.3	4.5±0.2	4.5±0.2	4.5±0.3	0.008
Aspartate aminotransferase (IU/L)	25.9±11.1	27.0±15.4	26.5±8.6	29.5±14.4	0.02
Alanine transaminase (IU/L)	25.3±14.6	27.0±23.6	27.3±13.2	30.1±17.3	0.04
γ-glutamyltransferase (IU/L)	44.0±65.6	42.1±85.2	41.5±42.7	60.3±86.9	0.01
Total bilirubin (mg/dL)	0.94±0.33	0.97±0.35	0.96±0.38	0.97±0.39	0.89
Blood urea nitrogen (mg/dL)	16.3±4.0	16.4±4.7	16.6±4.3	17.2±5.0	0.13
Creatinine (mg/dL)	0.99±0.12	1.02±0.12	1.05±0.13	1.11±0.24	<0.001
HDL cholesterol (mg/dL)	43.1±10.8	42.9±9.8	42.4±9.8	40.4±9.2	0.003
Total cholesterol (mg/dL)	189.0±32.8	190.1±31.9	194.6±34.2	189.5±33.8	0.25
Triglycerides (mg/dL)	140.2±110.9	157.0±119.5	159.0±90.1	198.7±139.5	<0.001
Fasting glucose (mg/dL)	101.8±27.1	98.2±20.5	96.7±18.4	99.1±19.1	0.12
HbA1c (%)	5.8±1.1	5.7±0.8	5.6±0.8	5.7±0.8	0.10
Insulin (uIU/mL)	7.6±3.1	8.0±3.5	8.1±3.3	8.6±3.2	0.02
C-reactive protein (mg/dL)	1.9±5.1	1.6±5.0	1.6±3.6	1.6±2.9	0.91
Smoking status
Non-smoker	144 (73.10)	163 (72.44)	166 (72.17)	180 (75.95)	0.781
Current smoker	53 (26.90)	62 (27.56)	64 (27.83)	57 (24.05)
Drinking status
Non-drinker	105 (53.30)	87 (38.67)	89 (38.70)	72 (30.38)	0.0011
Current drinker	92 (46.70)	138 (61.33)	141 (61.30)	165 (69.62)
Variables	Serum uric acid quartile (mg/dL)				p - value
	< 3.8 (n = 368)	3.8 - < 4.3 (n = 327)	4.3 - < 5.1 (n = 414)	≥ 5.1 (n = 382)
Female (n=1491)
Age (y)	56.3±8.1	56.1±8.1	57.2±8.0	59.0±8.0	<0.001
Body mass index (kg/m2)	23.9±3.0	24.5±2.9	24.9±3.3	25.9±3.5	<0.001
Waist circumference (cm)	85.4±8.9	87.0±8.0	87.9±7.9	90.1±8.7	<0.001
SBP (mmHg)	118.4±17.7	118.1±16.7	119.8±16.7	123.1±18.6	<0.001
DBP (mmHg)	70.2±10.1	71.3±9.2	72.1±9.8	73.0±9.6	0.001
Total protein (g/dL)	7.4±0.4	7.4±0.4	7.5±0.4	7.5±0.4	<0.001
Albumin (g/dL)	4.5±0.2	4.5±0.2	4.5±0.2	4.5±0.2	0.01
Aspartate aminotransferase (IU/L)	22.8±7.7	22.3±5.9	23.5±6.4	24.4±8.2	0.001
Alanine transaminase (IU/L)	20.3±11.9	19.5±8.2	21.2±9.5	23.2±12.2	<0.001
γ-glutamyltransferase (IU/L)	18.6±22.2	17.5±13.5	20.7±36.6	27.2±58.6	0.002
Total bilirubin (mg/dL)	0.84±0.30	0.83±0.30	0.83±0.43	0.80±0.28	0.30
Blood urea nitrogen (mg/dL)	14.5±3.9	15.2±3.9	15.2±4.2	16.3±4.4	<0.001
Creatinine (mg/dL)	0.82±0.10	0.83±0.09	0.85±0.09	0.92±0.16	<0.001
HDL cholesterol (mg/dL)	47.2±10.7	46.0±10.4	44.1±9.9	43.1±9.9	<0.001
Total cholesterol (mg/dL)	199.6±37.2	197.8±32.7	202.0±34.2	206.8±39.1	0.006
Triglycerides (mg/dL)	121.8±72.0	121.1±59.3	145.2±82.8	166.0±89.7	<0.001
Fasting glucose (mg/dL)	94.0±24.3	94.7±18.2	95.9±16.8	97.7±27.9	0.11
HbA1c (%)	5.6±0.8	5.6±0.9	5.7±0.7	5.9±1.0	<0.001
Insulin (uIU/mL)	8.2±3.0	8.4±3.4	8.8±3.5	9.6±3.9	<0.001
C-reactive protein (mg/dL)	1.3±3.8	1.2±4.2	1.4±2.4	1.8±2.4	0.10
Smoking status
Non-smoker	363 (98.64)	324 (99.08)	408 (98.55)	368 (96.34)	0.031
Current smoker	5 (1.36)	3 (0.92)	6 (1.45)	14 (3.66)
Drinking status
Non-drinker	274 (74.46)	253 (77.37)	310 (74.88)	281 (73.56)	0.691
Current drinker	94 (25.54)	74 (22.63)	104 (25.12)	101 (26.44)

Data were expressed as mean±SD or number (%).

SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL, high-density lipoprotein.

¹ Chi-squared test.

Table 2.

Correlation between serum uric acid and investigated variables

Variables	Male		Female
	Pearson’s coefficients	p - value	Pearson’s coefficients	p - value
Age (y)	-0.096	0.004	0.138	<0.001
Body mass index (kg/m2)	0.189	<0.001	0.226	<0.001
Waist circumference (cm)	0.163	<0.001	0.207	<0.001
SBP (mmHg)	0.086	0.01	0.053	0.04
DBP (mmHg)	0.005	0.95	0.083	0.14
Total protein (g/dL)	0.192	<0.001	0.155	<0.001
Albumin (g/dL)	0.086	0.01	0.069	0.008
Aspartate aminotransferase (IU/L)	0.116	0.001	0.102	<0.001
Alanine transaminase (IU/L)	0.104	0.002	0.113	<0.001
γ-glutamyltransferase (IU/L)	0.095	0.005	0.134	<0.001
Total bilirubin (mg/dL)	0.050	0.14	-0.046	0.07
Blood urea nitrogen (mg/dL)	0.103	0.002	0.181	<0.001
Creatinine (mg/dL)	0.323	<0.001	0.349	<0.001
Total cholesterol (mg/dL)	0.001	0.98	0.102	<0.001
HDL-cholesterol (mg/dL)	-0.119	<0.001	-0.154	<0.001
Log (triglycerides in mg/dL)	0.217	<0.001	0.252	<0.001
Log (fasting glucose in mg/dL)	-0.039	0.25	0.070	0.007
HbA1c (%)	-0.052	0.12	0.101	<0.001
Insulin (uIU/mL)	0.107	0.001	0.164	<0.001
Log (C-reactive protein in mg/L)	0.102	0.002	0.239	<0.001

SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL, high-density lipoprotein.

Table 3.

The association between serum uric acid level quartiles and metabolic syndrome

Serum uric acid quartile (mg/dL)	Odds ratio (95% confidence interval) for metabolic syndrome
	Unadjusted	Adjusted1
Male
1st (<4.8)	1.00	1.00
2nd (4.8-<5.6)	1.38 (0.91, 2.09)	1.72 (1.03, 2.88)
3rd (5.6-<6.5)	1.70 (1.13, 2.56)	1.94 (1.17, 3.22)
4th (≥6.5)	2.67 (1.78, 4.00)	2.67 (1.60, 4.46)
Female
1st (<3.8)	1.00	1.00
2nd (3.8-<4.3)	0.99 (0.73, 1.34)	0.86 (0.61, 1.23)
3rd (4.3-<5.1)	2.00 (1.50, 2.66)	1.62 (1.16, 2.25)
4th (≥5.1)	3.32 (2.46, 4.48)	2.14 (1.50, 3.05)

¹ Adjusted for age, smoking, alcohol intake, body mass index, total cholesterol, HbA1c, albumin, γ-glutamyltransferase, blood urea nitrogen, and C-reactive protein (log-transformed).

Figure & Data

References

Citations

Citations to this article as recorded by  

• Associations of triglyceride-glucose index with hyperuricemia among Royal Thai Army personnel
  Sethapong Lertsakulbunlue, Tanatip Sangkool, Varathpavee Bhuriveth, Mathirut Mungthin, Ram Rangsin, Anupong Kantiwong, Boonsub Sakboonyarat
  BMC Endocrine Disorders.2024;[Epub]     CrossRef
• Association of hyperuricemia with metabolic syndrome and its components in an adult population of Faisalabad, Pakistan
  Rameen Shahid, Misbah Hussain, Muhammad Umer Ghori, Ahmed Bilal, Fazli Rabbi Awan
  Nutrition, Metabolism and Cardiovascular Diseases.2024; 34(6): 1554.     CrossRef
• Uric acid and metabolic syndrome: Importance of hyperuricemia cut-off
  Alessandro Maloberti, Chiara Tognola, Ilaria Garofani, Michela Algeri, Atea Shkodra, Valentina Bellantonio, Marco Le Van, Stefano Pedroli, Marta Campana, Giorgio Toscani, Michele Bombelli, Cristina Giannattasio
  International Journal of Cardiology.2024; 417: 132527.     CrossRef
• The Association of Hyperuricemia with Glaucoma: A Nationwide Cross-Sectional Study from the Republic of Korea
  Eun Jin Koh, Jihei Sara Lee, Chan Yun Kim, Hyoung Won Bae
  Journal of the Korean Glaucoma Society.2024; 13(2): 83.     CrossRef
• Serum uric acid significantly improves the accuracy of cardiovascular risk score models
  Yonatan Moshkovits, Shmuel Tiosano, Alon Kaplan, Maia Kalstein, Gabriella Bayshtok, Shaye Kivity, Shlomo Segev, Ehud Grossman, Amit Segev, Elad Maor, Alexander Fardman
  European Journal of Preventive Cardiology.2023; 30(7): 524.     CrossRef
• Association between Neck Circumference and Serum Uric Acid Level in Korean Adults over 40 Years Old: Based on the 2019 Korea National Health and Nutrition Examination Survey
  Myeong Jin Lee, Hye Rim Hwang, Youn Mi Kim, Ki Woo Kim
  Korean Journal of Family Practice.2023; 13(1): 8.     CrossRef
• Correlation of Salivary Uric Acid and Cardiac Autonomic Modulation in Metabolic Syndrome Population
  Bhagyashree N, Ganesh M, Ramaswamy C
  Research Journal of Pharmacy and Technology.2023; : 1347.     CrossRef
• Dietary polyglycosylated anthocyanins, the smart option? A comprehensive review on their health benefits and technological applications
  Jingren He, Shuxin Ye, Patrícia Correia, Iva Fernandes, Rui Zhang, Muci Wu, Victor Freitas, Nuno Mateus, Hélder Oliveira
  Comprehensive Reviews in Food Science and Food Safety.2022;[Epub]     CrossRef
• Pharmacokinetics, Mass Balance, and Metabolism of the Novel Urate Transporter 1 Inhibitor [14C]HR011303 in Humans: Metabolism Is Mediated Predominantly by UDP-Glucuronosyltransferase
  Yuandong Zheng, Hua Zhang, Mengling Liu, Guangze Li, Sheng Ma, Zhe Zhang, Hongda Lin, Yan Zhan, Zhendong Chen, Dafang Zhong, Liyan Miao, Xingxing Diao
  Drug Metabolism and Disposition.2022; 50(6): 798.     CrossRef
• Seaweed sulfated polysaccharides and their medicinal properties
  Oxana Olegovna Zaitseva, Marta Igorevna Sergushkina, Andrey Nikolaevich Khudyakov, Tatyana Vitalyevna Polezhaeva, Olga Nurzadinovna Solomina
  Algal Research.2022; 68: 102885.     CrossRef
• Design, synthesis, and biological studies of dual URAT1 inhibitor and FXR agonist based on benzbromarone
  Wanqiu Huang, Shixuan Jiao, Siliang Chen, Ya Chen, Zhongcheng Yang, Wenxin Wang, Zhijun Cao, Zheng Li, Luyong Zhang
  Bioorganic & Medicinal Chemistry.2022; 75: 117073.     CrossRef
• Extract of Aster glehni ameliorates potassium oxonate-induced hyperuricemia by modulating renal urate transporters and renal inflammation by suppressing TLR4/MyD88 signaling
  Jeongho Jeong, Mi Kyung Lim, Eun Hye Han, Sang-Ho Lee, Seongman Kang, Soyeon Lee
  Food Science and Biotechnology.2022; 31(13): 1729.     CrossRef
• High Prevalence of Prediabetes and Associated Risk Factors in Urban Areas of Pontianak, Indonesia: A Cross-Sectional Study
  Indah Budiastutik, Martha I. Kartasurya, Hertanto W. Subagio, Bagoes Widjanarko, Mayank Choubey
  Journal of Obesity.2022; 2022: 1.     CrossRef
• The association of serum uric acid with metabolic syndrome and its components—From a single‐clinical centre in China
  Jian Xu, Chengcheng Liu, Li Fu, Li Li, Tingting Wang
  International Journal of Clinical Practice.2021;[Epub]     CrossRef
• Can biomarkers be used to improve diagnosis and prediction of metabolic syndrome in childhood cancer survivors? A systematic review
  Vincent G. Pluimakers, Selveta S. van Santen, Marta Fiocco, Marie‐Christine E. Bakker, Aart J. van der Lelij, Marry M. van den Heuvel‐Eibrink, Sebastian J. C. M. M. Neggers
  Obesity Reviews.2021;[Epub]     CrossRef
• Identification of biomarkers of brown adipose tissue aging highlights the role of dysfunctional energy and nucleotide metabolism pathways
  Carola Mancini, Sabrina Gohlke, Francisco Garcia-Carrizo, Vyacheslav Zagoriy, Heike Stephanowitz, Tim J. Schulz
  Scientific Reports.2021;[Epub]     CrossRef
• Peculiarities of Metabolic Factors of Cardiovascular Risk in Essential Hypertension Patients depending on Body Weight and Gender
  N. S. Bek, O. M. Radchenko, L. V. Olenych
  Ukraïnsʹkij žurnal medicini, bìologìï ta sportu.2020; 5(1): 96.     CrossRef
• Associations of Serum Uric Acid with Endogenous Cholesterol Synthesis Indices in Men with High Cardiometabolic Risk
  Marek Vecka, Aleš Žák, Eva Tvrzická, Magdalena Dušejovská, Barbora Staňková, Miroslav Zeman
  Metabolic Syndrome and Related Disorders.2020; 18(4): 212.     CrossRef
• Association of Serum Uric Acid with cardio-metabolic risk factors and metabolic syndrome in seafarers working on tankers
  Fereshteh Baygi, Kimmo Herttua, Ali Sheidaei, Alireza Ahmadvand, Olaf Chresten Jensen
  BMC Public Health.2020;[Epub]     CrossRef
• The association between serum uric acid level and the risk of cognitive impairment after ischemic stroke
  Jing Sun, Xinhuang Lv, Xinxin Gao, Zewei Chen, Dianhui Wei, Yi Ling, Junmei Zhang, Qilu Gu, Jiaming Liu, Weian Chen, Suzhi Liu
  Neuroscience Letters.2020; 734: 135098.     CrossRef
• The Association Between Metabolic Syndrome and Serum Concentrations of Micronutrients, Inflammation, and Oxidative Stress Outside of the Clinical Reference Ranges: A Cross-Sectional Study
  Thirumagal Kanagasabai, Khloud Alkhalaqi, James R. Churilla, Chris I. Ardern
  Metabolic Syndrome and Related Disorders.2019; 17(1): 29.     CrossRef
• Chicory (Cichorium intybus L.) inhibits renal reabsorption by regulating expression of urate transporters in fructose-induced hyperuricemia
  Yu Wang, Zhijian Lin, Bing Zhang, Xiao Wang, Mengzhen Chu
  Journal of Traditional Chinese Medical Sciences.2019; 6(1): 84.     CrossRef
• Uric Acid Levels Correlate with Sensory Nerve Function in Healthy Subjects
  Alon Abraham, Hans D. Katzberg, Leif E. Lovblom, Bruce A. Perkins, Vera Bril
  Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.2019; 46(3): 337.     CrossRef
• Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2016–2019)
  Yue Dong, Tong Zhao, Wei Ai, Waleed A. Zalloum, Dongwei Kang, Ting Wu, Xinyong Liu, Peng Zhan
  Expert Opinion on Therapeutic Patents.2019; 29(11): 871.     CrossRef
• An association of smoking with serum urate and gout: A health paradox
  Niamh Fanning, Tony R. Merriman, Nicola Dalbeth, Lisa K. Stamp
  Seminars in Arthritis and Rheumatism.2018; 47(6): 825.     CrossRef
• Baseline and changes in serum uric acid independently predict 11-year incidence of metabolic syndrome among community-dwelling women
  R. Kawamoto, D. Ninomiya, Y. Kasai, K. Senzaki, T. Kusunoki, N. Ohtsuka, T. Kumagi
  Journal of Endocrinological Investigation.2018; 41(8): 959.     CrossRef
• Production Inhibition and Excretion Promotion of Urate by Fucoidan from Laminaria japonica in Adenine-Induced Hyperuricemic Mice
  Dayan Zhang, Huazhong Liu, Ping Luo, Yanqun Li
  Marine Drugs.2018; 16(12): 472.     CrossRef
• Association between Mean Corpuscular Hemoglobin Concentration and Future Depressive Symptoms in Women
  Ju-Mi Lee, Sarah B. Nadimpalli, Jin-Ha Yoon, Se Yeon Mun, Il Suh, Hyeon Chang Kim
  The Tohoku Journal of Experimental Medicine.2017; 241(3): 209.     CrossRef
• Screening of effective xanthine oxidase inhibitors in dietary anthocyanins from purple sweet potato (Ipomoea batatas L. Cultivar Eshu No.8) and deciphering of the underlying mechanisms in vitro
  Zi-Cheng Zhang, Hong-Bin Wang, Qing Zhou, Ben Hu, Jia-Hao Wen, Jiu-Liang Zhang
  Journal of Functional Foods.2017; 36: 102.     CrossRef
• Association of Education, Health Behaviors, Concerns, and Knowledge with Metabolic Syndrome among Urban Elderly in One Medical Center in Taiwan
  Meng-Ting Tsou
  International Journal of Gerontology.2017; 11(3): 138.     CrossRef
• Serum uric acid: a new therapeutic target for nonalcoholic fatty liver disease
  Dan-Qin Sun, Sheng-Jie Wu, Wen-Yue Liu, Qian-Di Lu, Gui-Qi Zhu, Ke-Qing Shi, Martin Braddock, Dan Song, Ming-Hua Zheng
  Expert Opinion on Therapeutic Targets.2016; 20(3): 375.     CrossRef
• Serum uric acid: A strong and independent predictor of metabolic syndrome after adjusting for body composition
  Tae Yang Yu, Jae Hwan Jee, Ji Cheol Bae, Sang-Man Jin, Jong-Ha Baek, Moon-Kyu Lee, Jae Hyeon Kim
  Metabolism.2016; 65(4): 432.     CrossRef
• Obésité, hyperuricémie et goutte
  Gérard Chalès, Pascal Richette
  Revue du Rhumatisme Monographies.2016; 83(1): 44.     CrossRef
• Serum uric acid concentration and metabolic syndrome among elderly Koreans: The Korean Urban Rural Elderly (KURE) study
  Hansol Choi, Hyeon Chang Kim, Bo Mi Song, Ji Hye Park, Ju-Mi Lee, Da-Lim Yoon, Young Mi Yoon, Yumie Rhee, Yousik Youm, Chang Oh Kim
  Archives of Gerontology and Geriatrics.2016; 64: 51.     CrossRef
• Biomarkers of Metabolic Syndrome: Biochemical Background and Clinical Significance
  Harry Robberecht, Nina Hermans
  Metabolic Syndrome and Related Disorders.2016; 14(2): 47.     CrossRef
• Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Tromsø Study
  Jon V. Norvik, Hilde M. Storhaug, Kirsti Ytrehus, Trond G. Jenssen, Svetlana N. Zykova, Bjørn O. Eriksen, Marit D. Solbu
  BMC Cardiovascular Disorders.2016;[Epub]     CrossRef
• Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome
  Amedeo Lonardo, Stefano Ballestri, Giulio Marchesini, Paul Angulo, Paola Loria
  Digestive and Liver Disease.2015; 47(3): 181.     CrossRef
• Associations between serum uric acid concentrations and metabolic syndrome and its components in the PREDIMED study
  N. Babio, M.A. Martínez-González, R. Estruch, J. Wärnberg, J. Recondo, M. Ortega-Calvo, L. Serra-Majem, D. Corella, M. Fitó, E. Ros, N. Becerra-Tomás, J. Basora, J. Salas-Salvadó
  Nutrition, Metabolism and Cardiovascular Diseases.2015; 25(2): 173.     CrossRef
• Prevalence of metabolic syndrome and pre-metabolic syndrome in health professionals: LATINMETS Brazil study
  Fernanda de Carvalho Vidigal, Andréia Queiroz Ribeiro, Nancy Babio, Jordi Salas-Salvadó, Josefina Bressan
  Diabetology & Metabolic Syndrome.2015;[Epub]     CrossRef
• Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome: Results from Fangchenggang Area Male Health and Examination Survey in China
  Dongni Chen, Haiying Zhang, Yong Gao, Zheng Lu, Ziting Yao, Yonghua Jiang, Xinggu Lin, Chunlei Wu, Xiaobo Yang, Aihua Tan, Zengnan Mo
  Clinica Chimica Acta.2015; 446: 226.     CrossRef
• Antioxidative phytochemicals from Rhododendron oldhamii Maxim. leaf extracts reduce serum uric acid levels in potassium oxonate-induced hyperuricemic mice
  Yu-Tang Tung, Lei-Chen Lin, Ya-Ling Liu, Shang-Tse Ho, Chi-Yang Lin, Hsiao-Li Chuang, Chien-Chao Chiu, Chi-Chang Huang, Jyh-Horng Wu
  BMC Complementary and Alternative Medicine.2015;[Epub]     CrossRef
• Mangiferin Inhibits Renal Urate Reabsorption by Modulating Urate Transporters in Experimental Hyperuricemia
  Hua Yang, Lihui Gao, Yanfen Niu, Yuanfang Zhou, Hua Lin, Jing Jiang, Xiangfu Kong, Xu Liu, Ling Li
  Biological & Pharmaceutical Bulletin.2015; 38(10): 1591.     CrossRef
• Serum Uric Acid and Subsequent Cognitive Performance in Patients with Pre-Existing Cardiovascular Disease
  Noa Molshatzki, Galit Weinstein, Jonathan Y. Streifler, Uri Goldbourt, David Tanne, Hemachandra Reddy
  PLOS ONE.2015; 10(3): e0120862.     CrossRef
• Serum uric acid does not predict incident metabolic syndrome in a population with high prevalence of obesity
  L.A. Ferrara, H. Wang, J.G. Umans, N. Franceschini, S. Jolly, E.T. Lee, J. Yeh, R.B. Devereux, B.V. Howard, G. de Simone
  Nutrition, Metabolism and Cardiovascular Diseases.2014; 24(12): 1360.     CrossRef
• Comorbidities in Patients with Crystal Diseases and Hyperuricemia
  Sebastian E. Sattui, Jasvinder A. Singh, Angelo L. Gaffo
  Rheumatic Disease Clinics of North America.2014; 40(2): 251.     CrossRef
• Association between Serum 25-Hydroxyvitamin D Level and Insulin Resistance in a Rural Population
  Bo Mi Song, Hyeon Chang Kim, Dong Phil Choi, Sun Min Oh, Il Suh
  Yonsei Medical Journal.2014; 55(4): 1036.     CrossRef
• Relationship between serum uric acid levels and metabolic syndrome in Chinese postmenopausal women
  P. J. Liu, F. Ma, H. P. Lou, Y. N. Zhu, Y. Chen
  Climacteric.2014; 17(2): 148.     CrossRef
• A possible role of serum uric acid as a marker of metabolic syndrome
  Y.‐J. Lee, S. Cho, S. R. Kim
  Internal Medicine Journal.2014; 44(12a): 1210.     CrossRef
• The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome
  Federico Carbone, Fabrizio Montecucco, François Mach, Roberto Pontremoli, Francesca Viazzi
  Thrombosis and Haemostasis.2013; 110(11): 940.     CrossRef
• Hyperuricaemia
  Niki Katsiki, Asterios Karagiannis, Vasilios G. Athyros, Dimitri P. Mikhailidis
  Journal of Cardiovascular Medicine.2013; 14(6): 397.     CrossRef
• Metabolic syndrome, diabetes, and hyperuricemia
  Changgui Li, Ming-Chia Hsieh, Shun-Jen Chang
  Current Opinion in Rheumatology.2013; 25(2): 210.     CrossRef
• Risk factors for incident hyperuricemia during mid-adulthood in African American and White men and women enrolled in the ARIC cohort study
  Mara A McAdams-DeMarco, Andrew Law, Janet W Maynard, Josef Coresh, Alan N Baer
  BMC Musculoskeletal Disorders.2013;[Epub]     CrossRef
• The Effects of Consumption L-Arabinose on Metabolic Syndrome in Humans
  Ziming, Dianpeng Li, Haiying Jiang, Guiyun Qian, Weiguo Sui, Guimian Zou, Hourui Zhang
  Journal of Pharmacy and Nutrition Sciences .2013; 3(2): 116.     CrossRef
• Effects of the Degree of Obesity on Achieving Target Blood Pressure and Metabolic Deterioration in Obese Individuals: A Population-Based Study
  Serkan Ozturk, Davut Baltaci, Yasemin Turker, Ali Kutlucan, Erhan Yengil, Mehmet Harun Deler, Mucahit Gur, Handan Ankarali
  Kidney and Blood Pressure Research.2013; 37(6): 531.     CrossRef